|
Market Closed -
Bombay S.E.
11:02:35 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 111.95 INR | +8.22% |
|
-2.65% | -13.88% |
| Market Cap | 1.29B 13.54M 12.1M 11.17M 10.13M 18.94M 19.26M 134M 53.24M 674M 50.83M 49.75M 2.12B | P/E 2025 |
10.7x | P/E 2026 | 12.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 22.03M 19.67M 18.17M 16.47M 30.81M 31.32M 219M 86.57M 1.1B 82.67M 80.91M 3.45B | EV / Sales 2025 |
1.02x | EV / Sales 2026 | 0.92x |
| Free-Float |
14.66% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| PARNAXLAB | Delayed | |
NSE India S.E.
| PARNAXLAB | Delayed |
| 1 day | +8.22% | ||
| 1 week | -2.65% | ||
| Current month | +0.40% | ||
| 1 month | -8.54% | ||
| 3 months | -20.06% | ||
| 6 months | -30.47% | ||
| Current year | -13.88% |
| 1 week | 101.95 |  | 121 |
| 1 month | 101.95 | | 121 |
| Current year | 99.2 | | 182 |
| 1 year | 99.2 | | 182 |
| 3 years | 75.6 | | 193.5 |
| 5 years | 23.35 | | 193.5 |
| 10 years | 11.65 | | 193.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 04/07/2024 | |
Binoy Baiju Shah
DFI | Director of Finance/CFO | 42 | 04/07/2024 |
| Compliance Officer | - | 20/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ami Mihir Shah
BRD | Director/Board Member | 50 | 30/03/2015 |
| Director/Board Member | 72 | 27/05/2021 | |
| Director/Board Member | 67 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.22% | -2.65% | -13.62% | +29.89% | 13.54M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -0.16% | +1.69% | +31.96% | +65.23% | 400.37B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.88B 19.78M 17.66M 16.32M 14.79M 27.67M 28.12M 196M 77.75M 984M 74.24M 72.66M 3.1B | 2.49B 26.19M 23.39M 21.6M 19.58M 36.63M 37.23M 260M 103M 1.3B 98.28M 96.19M 4.11B |
| Net income | 115M 1.21M 1.08M 1M 907K 1.7M 1.73M 12.05M 4.77M 60.35M 4.55M 4.46M 190M | 118M 1.24M 1.11M 1.02M 927K 1.74M 1.76M 12.32M 4.88M 61.7M 4.66M 4.56M 195M |
| Net Debt | 690M 7.27M 6.49M 5.99M 5.43M 10.16M 10.33M 72.13M 28.56M 361M 27.27M 26.69M 1.14B | 805M 8.48M 7.57M 7M 6.34M 11.86M 12.06M 84.21M 33.34M 422M 31.83M 31.16M 1.33B |
Employees
12
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | ₹111.95 | +8.22% | 1,250 |
| 21/10/26 | ₹103.45 | -4.70% | 594 |
| 19/10/26 | ₹108.55 | -5.61% | 127 |
| 16/10/26 | ₹115.00 | +4.31% | 126 |
- Stock Market
- Stocks
- PARNAXLAB Stock
Select your edition
All financial news and data tailored to specific country editions
